Bio-Gene Technology Ltd (BGT) — Capital Reinvestment Ratio
Bio-Gene Technology Ltd (BGT) has a Capital Reinvestment Ratio of 0.16x as of June 2022, meaning it reinvests 0% of its operating cash flow (AU$43.52K) in capital expenditures (AU$6.84K). See BGT equity to assets ratio to measure how much of total assets are equity-financed.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Bio-Gene Technology Ltd Capital Reinvestment Ratio (2022–2022)
This chart tracks Bio-Gene Technology Ltd's Capital Reinvestment Ratio across 1 annual periods. Check BGT cash flow reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
Annual Capital Reinvestment Ratio for Bio-Gene Technology Ltd (2022–2022)
Year-by-year Capital Reinvestment Ratio for Bio-Gene Technology Ltd from 2022 to 2022. For live market cap and broader valuation context, see BGT market cap overview.
| Year | Reinvestment Ratio | Operating CF (AUD) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2022 | 0.16x | AU$43.52K | AU$6.84K | — |